Journal
The New England Journal of Medicine
Publication Date
2012
Volume
366
Issue
9
Inclusive Pages
799-807
Document Type
Open Access Publication
DOI
pdf/10.1056/NEJMoa1110557
Rights and Permissions
Verstovsek, S., Mesa, R. A., Gotlib, J., Levy, R. S., Gupta, V., DiPersio, J. F., . . . Kantarjian, H. M. (2012). A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. New England Journal of Medicine, 366(9), 799-807. Copyright © 2012 Massachusetts Medical Society. doi: 10.1056/NEJMoa1110557. http://www.nejm.org/doi/pdf/10.1056/NEJMoa1110557.
Recommended Citation
DiPersio, John F. and et al, "A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis." The New England Journal of Medicine. 366, 9. 799-807. (2012).
https://digitalcommons.wustl.edu/open_access_pubs/2909
